Modulight receives order worth 0.5 MEUR
Translation: Original published in Finnish on 12/20/2024 at 7:22 am EET.
Modulight announced on Thursday that it has received an order worth 0.5 MEUR from a customer in the field of next-generation therapeutics. Delivery of the order is scheduled for the second half of 2025 and the first half of 2026.
This order will contribute to the strong growth we expect for Modulight in the coming years. This year, we forecast revenue to amount to 3.9 MEUR, but to increase to 7.7 MEUR (+100%) and 10.6 MEUR (+38%) in 2025-2026. In November, the company announced new contracts with a minimum value of 1.5 MEUR for the next two years. Thus, Modulight's revenue development in the coming years has recently gained a notch more visibility with the new agreements.
Modulight
Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.
Read more on company pageKey Estimate Figures22.10
2023 | 24e | 25e | |
---|---|---|---|
Revenue | 4.0 | 3.9 | 7.7 |
growth-% | -12.46 % | -4.08 % | 99.57 % |
EBIT (adj.) | -12.1 | -8.1 | -6.3 |
EBIT-% (adj.) | -301.39 % | -210.90 % | -81.75 % |
EPS (adj.) | -0.28 | -0.18 | -0.12 |
Dividend | 0.00 | 0.00 | 0.00 |
Dividend % | |||
P/E (adj.) | - | - | - |
EV/EBITDA | - | - | - |